Newsroom

2005 News Releases

  • Emory Eye Center Begins Clinical Trial For New Ocular Prosthetic Device That Allows Better Motility
    ATLANTA - Emory Eye Center has begun a new clinical trial to evaluate the efficacy of a new prosthetic ocular device, made by Porex Surgical, Inc. The device, the MEDPOR" ATTRACTOR, Coupling System will offer patients who need a prosthetic eye a better alternative than ever before.
    December 5, 2005

  • Emory Eye Center Announces New Two-Year Neuro-Ophthalmology Fellowship
    (ATLANTA) Emory Eye Center has recently announced the creation of a new, fully-funded, two year Neuro-Ophthalmology Fellowship to begin July 1, 2006.
    The beauty of the new fellowship is that it can be tailored to the particular fellow. It is specifically designed to be a flexible two-year training of either ophthalmology or neurology trained physicians, individually tailored to the particular needs and interests of the applicant. One of the fellowship years will remain a traditionally-focused year of academic neuro-ophthalmic training, while the other year will be customized to the particular fellow.
    July 25, 2005

  • Emory Eye Center Among First to Offer New Multi-focal IOL For Cataract Patients Freedom from Glasses a Plus
    (ATLANTA) Emory Eye Center is now offering a newly FDA-approved intraocular lens (IOL) for cataract patients. The lens provides them with a new option for post-surgery vision correction-that of freedom from glasses. The lens provides near, intermediate and far vision capabilities.
    July 21, 2005

  • Emory Eye Center Research Director Receives Proctor Award at Recent Association for Research in Vision & Ophthalmology (ARVO) Conference
    (ATLANTA) Henry F. Edelhauser, PhD, received the Proctor Medal and delivered the Proctor Lecture at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Ft. Lauderdale, Fla., on May 2. Dr. Edelhauser, the director of research for Emory Eye Center, was presented with ARVO's highest honor for his ground breaking work on the physiology of the corneal endothelium and for "elegant translational research from basic science to clinical applications."
    May 31, 2005

  • Emory Eye Center staff assists in nationwide eye screening for glaucoma
    (ATLANTA) Emory Eye Center professionals are assisting Emory School of Medicine (SOM) third- and fourth-year students to administer the Student Sight Savers Program, a national program to help screen for glaucoma. The screening is at no cost for the patient. Those at risk for developing glaucoma include African Americans over 35 years of age and persons with diabetes. The screening includes: optic nerve assessment, pressure check and visual field assessment. Those patients needing follow-up will be seen at Grady Hospital's eye clinic.
    April 12, 2005

  • Emory Eye Center study says that older children can benefit from treatment for childhood's most common eye disorder
    ( ATLANTA) Surprising results from a nationwide clinical trial show that many children age seven through 17 with amblyopia (lazy eye) may benefit from treatments that are more commonly used on younger children. Treatment improved the vision of many of the 507 older children with amblyopia studied at 49 eye centers. Previously, eye care professionals often thought that treating amblyopia in older children would be of little benefit. The study results, funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), appears in the April issue of Archives of Ophthalmology.
    April 11, 2005

  • Emory Eye Center implants its first retinal chips in patients with Retinitis Pigmentosa in expanded U.S. clinical trial
    (ATLANTA) An expanded clinical trial conducted by Optobionics Corporation involving the implantation of a retina mircrochip has allowed Emory Eye Center and the Atlanta Veterans Affairs Rehabilitation Research & Development Center to implant the device in several patients. The patients all have retinitis pigmentosa with moderate-to-severe vision loss. Three centers in the United States have been chosen to conduct the expanded trial. Other than Emory and the VA Rehabilitation R&D Center they include Rush University Medical Center’s Department of Ophthalmology and the Wilmer Eye Institute at Johns Hopkins Medical Center.
    February 10, 2005

  • New drug for "Wet" Macular Degeneration offers new treatment for the blinding disease says Emory Eye Center physician
    (ATLANTA) A new drug for treatment of the wet form of age-related macular degeneration, known as AMD, has been approved by the FDA recently. AMD is a serious disease of the retina that can lead to severe vision loss and blindness.
    February 10, 2005

  • Emory Eye Center offers new vision correction procedure to help those who are not candidates for LASIK or are severely myopic
    (ATLANTA) For those people who have dealt with severe degrees of myopia yet have not been good candidates for surgeries such as LASIK, a new implant may provide them new hope-and new vision.
    January 19, 2005

  • Doctors urge eye exams during glaucoma awareness month
    Hispanics Should Take Special Note
    ATLANTA -- The bad news is that glaucoma, a condition associated with elevated pressure inside the eye, can damage the optic nerve and cause vision loss, currently affects more than three million Americans. The good news is that eye researchers throughout the country are working on preventing this disease. Recent findings also show that the burgeoning Latino population is at higher risk than expected for this disease.
    January 3, 2005

Our Emory campus location:

Copyright © Emory Eye Center - All Rights Reserved | Emory Clinic Building B, 1365B Clifton Road, NE, Atlanta, Georgia 30322 USA